???global.info.a_carregar???
Rui Bergantim completed his PhD in Medicine and Molecular Oncology in 2025 at the Universidade do Porto, where he also earned his Medical Degree in 2006. He currently holds multiple academic and clinical roles, including Invited Assistant at the Faculty of Medicine, Universidade do Porto, and Clinical Hematologist at both the Centro Hospitalar Universitário de São João and Hospital Lusíadas Porto. In addition, he is a Researcher at the Instituto de Investigação e Inovação em Saúde (i3S) at Universidade do Porto and contributes to Science and Technology Management within the European Cooperation in Science and Technology (COST). Throughout his career, Rui Bergantim has demonstrated a strong commitment to scientific research and academic development. He has authored 50 peer-reviewed journal articles, contributed to 4 book sections, and organized five scientific events. He has supervised 2 MSc dissertations and co-supervised 1 MSc dissertation, and has been recognized with 13 awards and honors for his contributions to science and medicine. He has played active roles in numerous research projects, serving as Principal Investigator (PI) in 12 projects, Co-Principal Investigator (Co-PI) in 6 projects, and contributing in other roles to 2 additional projects.
Read full resume ↓
Identification

Personal identification

Full name
Rui Filipe Cordeiro Bergantim

Citation names

  • Bergantim, Rui

Author identifiers

Ciência ID
E81D-4592-150E
ORCID iD
0000-0002-7811-9509
AuthenticusID
6603
Google Scholar ID
yfB3R_EAAAAJ
Researcher Id
AAI-9380-2020
Scopus Author Id
55258732700

Email addresses

  • rui.bergantim@gmail.com (Professional)
  • rbergantim@ipatimup.pt (Professional)
  • rui.bergantim@chsj.min-saude.pt (Professional)

Addresses

  • Centro Hospitalar e Universitário São João, 4200-319, Porto, Porto, Portugal (Professional)
  • i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto, 4200-135, Porto, Porto, Portugal (Professional)

Websites

Knowledge fields

  • Medical and Health Sciences - Clinical Medicine - Hematology
  • Medical and Health Sciences - Clinical Medicine - Transplantation
  • Medical and Health Sciences - Clinical Medicine - Oncology

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
English Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Beginner (A1) Beginner (A1) Beginner (A1) Beginner (A1)
Education
Degree Classification
2013 - 2025
Concluded
 Medicina e Oncologia Molecular (Doutoramento)
Universidade do Porto, Portugal
"Searching for biomarkers of measurable residual disease and of drug resistance in liquid biopsies from multiple myeloma patients" (THESIS/DISSERTATION)
2023 - 2023
Concluded
 Consultant in Clinical Hematology (Outros)
Administração Central do Sistema de Saúde IP, Portugal
 18,70
2008 - 2013
Concluded
 Specialist in Clinical Hematology (Título de especialista)
Ordem dos Médicos, Portugal
 19,80
2000 - 2006
Concluded
 Medicine (Licenciatura)
Universidade do Porto, Portugal
 15,36
Affiliation

Science

Category
Host institution 		Employer
2023 - Current Science and Technology Management European Cooperation in Science and Technology, Belgium
European Cooperation in Science and Technology, Belgium
2013 - Current Researcher (Research) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Teaching in Higher Education

Category
Host institution 		Employer
2020 - Current Invited Assistant (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal
2016 - 2019 Assistant (University Teacher) Universidade do Porto Faculdade de Medicina, Portugal

Positions / Appointments

Category
Host institution 		Employer
2018 - Current Clinical Hematologist Hospital Lusíadas Porto, Portugal
2013 - Current Clinical Hematologist Centro Hospitalar Universitário de São João, Portugal
2008 - 2012 Resident in Clinical Hematology Centro Hospitalar Universitário de São João, Portugal
2007 - 2007 Intern Hospital do Divino Espírito Santo de Ponta Delgada EPE, Portugal

Others

Category
Host institution 		Employer
2011 - 2011 Visiting Fellow Seattle Cancer Care Alliance, United States
Fred Hutchinson Cancer Research Center, United States
Projects

Grant

Designation Funders
2019 - 2021 LOOKER - Detection of minimal residual disease biomarkers in extracellular vesicles from liquid biopsies of multiple myeloma patients
GRANT-PRT-133
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Celgene Portugal
Concluded
2014 - 2017 m^3 - microRNAs as biomarkers of drug response/resistance in Multiple Myeloma
GRANT - APCL/SPH/AMGEN
Principal investigator
Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Associação Portuguesa Contra a Leucemia

Sociedade Portuguesa de Hematologia

Amgen Biofarmaceutica Lda
Concluded
2005/04/15 - 2008/10/14 EPIcardis III - Compreender a epidemiologia da insuficiência cardíaca através de dados longitudinais
POCI/SAU-ESP/61492/2004
Researcher
Universidade do Porto Faculdade de Medicina, Portugal

Universidade do Porto Unidade de Investigação e Desenvolvimento Cardiovascular, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Contract

Designation Funders
2022 - Current CarMMa - CARacterização da população de doentes Mieloma Multiplo tratados em hospitais portugueses e dos seus cuidAdores
CarMMa
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Grupo Português de Mieloma Múltiplo
Ongoing
2022 - Current DarMMa - Experiência De Vida Real Portuguesa Com Daratumumab Em Mieloma Múltiplo Em Primeira Linha E Recaída/Progressão
DarMMa
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Grupo Português de Mieloma Múltiplo
Ongoing
2017 - 2021 Hevy_MM - Estudo da utilidade clínica do novo biomarcador sérico - HevyLite - no acompanhamento de doentes de Mieloma Múltiplo candidatos a transplante autólogo de progenitores hematopoiéticos de sangue periférico
HevyLite_MM
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário de São João, Portugal
 Binding Site Group Ltd
Concluded
2019/01/01 - 2019/12/31 Institute for Research and Innovation in Health Sciences
UID/BIM/04293/2019
LA/P/0070/2020
10.54499/LA/P/0070/2020
Instituto Nacional de Engenharia Biomédica, Portugal

Universidade do Porto, Portugal

Universidade do Porto Instituto de Biologia Molecular e Celular, Portugal

Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Universidade do Porto Instituto de Patologia e Imunologia Molecular, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2024 - Current A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma (MajesTEC-7)
NCT05552222
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Janssen-Cilag Farmacêutica Lda
Ongoing
2024 - Current Caracterizar infeções e as suas consequências em doentes com Mieloma Múltiplo Recidivante/Refratário (MMRR) tratados com Teclistamab – Estudo SPOT
64007957MMY4011
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Janssen-Cilag Farmacêutica Lda
Ongoing
2023 - Current IMMUNO-model COST ACTION
CA21135
Co-Leader of WG4 - Hematological Diseases
European Cooperation in Science and Technology, Belgium
 European Cooperation in Science and Technology
Ongoing
2014 - Current TOURMALINE MM3 - A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients with Multiple Myeloma Following Autologous Stem Cell Transplant
NCT02181413
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Millennium Pharmaceuticals Inc
Concluded
2019 - 2024 CharisMMa-Portugal - Caracterização clínica e socio demográfica de doentes com mieloma múltiplo em recidivae/ou refratário sintomático em Portugal: estudo observacional, multicêntrico.
NCT04135963
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Takeda Farmacêuticos Portugal
Concluded
2019 - 2024 EXPLORE - Health-related Quality of Life changes in Newly Diagnosed Multiple Myeloma (NDMM) Patients, Ineligible for Transplant aged 65 years and older, and First Relapse Multiple Myeloma (RMM) in adult patients, in usual clinical practice in Portugal
54767414MMY4043
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário de São João, Portugal
 Janssen-Cilag Farmacêutica Lda
Concluded
2019 - 2024 MRDeep - Prevalence of minimal residual disease (MRD) in patients with Multiple Myeloma (MM) who reach complete response (CR) and are currently in the 2nd or 3rd lines of treatment for MM
54767414MMY4025
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário de São João, Portugal
 Janssen-Cilag Farmacêutica Lda
Concluded
2015 - 2024 TOURMALINE MM4 - A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)
NCT02312258
Co-Principal Investigator (Co-PI)
Millennium Pharmaceuticals Inc
Concluded
2022 - 2023 EXCALIBER - Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Bristol-Myers Squibb Farmacêutica Portuguesa SA
Concluded
2019 - 2022 EMN23 - A retrospective observational multicenter study on mangement and outcome of patientswith systemic AL amyloidosis in Europe
NCT04937777
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 European Myeloma Network
Concluded
2016 - 2022 PrObe-L - Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma
NCT02692339
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Celgene Portugal
Concluded
2015 - 2022 IMROZ - Clinical Benefit of SAR650984, Bortezomib, Lenalidomide and Dexamethasone Combination in NDMM Patients Not Eligible for Transplant
NCT03319667
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário de São João, Portugal
 Sanofi Portugal
Concluded
2017 - 2019 ICARIA - Multinational Clinical Study Comparing Isatuximab, Pomalidomide, and Dexamethasone to Pomalidomide and Dexamethasone in Refractory or Relapsed and Refractory Multiple Myeloma Patients
NCT02990338
Principal investigator
Centro Hospitalar Universitário de São João, Portugal
 Sanofi Portugal
Concluded
2013 - 2016 POLO-AML-2 - Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy
NCT01721876
Co-Principal Investigator (Co-PI)
Centro Hospitalar Universitário de São João, Portugal
 Boehringer Ingelheim Portugal
Concluded
Outputs

Publications

Book
  1. Adriana Roque; Catarina Geraldes; Cristina João; Bergantim, Rui. Hot topics - Amiloidoise e outras gamapatias monoclonais de significado clínico. Portugal: Permanyer Portugal. 2025.
    Published • Editor
Book chapter
  1. Bergantim, Rui; Jorge, Joana ; Peixoto da Silva, Sara; Alves, Raquel; Gonçalves, Ana Cristina; Sarmento-Ribeiro, Ana Bela; Guimarães, José E.; Vasconcelos, M. Helena. "The Role of MicroRNAs in Mature B-Cell Neoplasias Drug Resistance (co-author)". In Reference Module in Biomedical Sciences. Elsevier, 2024.
    Published • 10.1016/b978-0-443-15717-2.00013-5
  2. Marini, C., Maia, T., Aguiar, E., Cancela, J., Bergantim, R., & Trigo, F. "A Case–Control Retrospective Observational Study in Multiple Myeloma". In Research Methods. SAGE Publications Ltd, 2020.
    https://dx.doi.org/10.4135/9781529742893
  3. Bergantim, Rui. "Infections in hematological patients". In Proceedings for Hematological Residents, 26-44. Porto: Serviço de Hematologia Clínica, Centro Hospitalar e Universitário São João, 2011.
    Published
  4. Bergantim, Rui. "Chemotherapy protocols for stem cell mobilization and autologous stem cell transplant". In Proceedings for Hematological Residents, 45-63. Porto, Portugal: Centro Hospitalar e Universitário São João, 2011.
    Published
Conference abstract
  1. Adriana Roque; Carlos Costa; Manuel Neves; Ana Bela Sarmento-Ribeiro; Rita Gerivaz; Ana Luisa Tome; Helena Martins; et al. "Quality of life of Portuguese multiple myeloma patients and its relationship with caregivers – a national study". Paper presented in 29th Congress of the European Hematology Association, Madrid, 2024.
    Published • https://doi.org/10.1002/hem3.104
  2. Carlos BT Costa; Manuel Neves; Adriana Isabel Roque; Ana Bela Sarmento-Ribeiro; Rita Gerivaz; Ana Tomé; Sofia Afonso; et al. "Assessment of Multiple Myeloma-Related Burden on Caregivers - a Portuguese National Study". Paper presented in 67th American Society of Hematology (ASH) Annual Meeting and Exposition, San Diego, 2023.
    Published • 10.1182/blood-2023-182698
  3. Rui Bergatim; José Guilherme Freitas; Cristina Gonçalves; Helena Martins; Herlander Marques; Henrique Coelho; Patrícia Seabra; et al. "Clinical and sociodemographic characterization of multiple myeloma patients with symptomatic relapse and/or refractory disease under treatment in Portugal: an observational, multicenter study". Paper presented in International Myeloma Society Meeting, Athens, 2023.
    Published • 10.1016/s2152-2650(23)01853-0
  4. Rui Bergantim; Catarina Geraldes; Cristina João; Paulo Lúcio; Manuel Neves; Fernanda Trigo; Miguel Pereira Ventura; Diogo Ramos. "Evolution of the multiple myeloma treatment landscape in Portugal: a 5-year longitudinal analysis of treatment patterns in nationwide clinical practice". Paper presented in International Myeloma Society Meeting, Athens, 2023.
    Published • 10.1016/s2152-2650(23)01796-2
  5. Rui Bergantim; Sara Peixoto da Silva; Joana Pereira; Vanessa Pinto; Diana Sousa; Rune Matthiesen; José Eduardo Guimarães; M. Helena Vasconcelos. "Identifying microRNAs as potential biomarkers of drug resistance in multiple myeloma patients: proof-of-concept study". Paper presented in International Myeloma Society Meeting, Los Angeles, 2022.
    10.1016/s2152-2650(22)00388-3
  6. Rui Bergantim; Sara Peixoto da Silva; Barbara Polónia; Mélanie A.G. Barbosa; Hugo R. Caires; José Eduardo Guimarães; M. Helena Vasconcelos. "Studying microRNAs from extracellular vesicles as potential biomarkers in liquid biopsies of multiple myeloma patients". Paper presented in International Myeloma Society Meeting, Los Angeles, 2022.
    10.1016/s2152-2650(22)00387-1
  7. Lamure, Sylvain; Salmanton-García, Jon; Robin-Marieton, Elena; Jakšic, Ozren; Kohn, Milena; Marchesi, Francesco; Marchetti, Monia; et al. "COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey". Paper presented in 66th American Society of Hematology (ASH) Annual Meeting and Exposition, New Orleans, 2022.
    Published • https://doi.org/10.1182/bloodadvances.2022007357
  8. Jaccard, A; Bridoux, F; Roeloffzen, W; Minnema, M. ; Bergantim, R; Hájek, R; João, C; Cibeira, M. T; Palladini, G; Schön. "HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH LIGHT CHAIN AMYLOIDOSIS IN EUROPE". Paper presented in 25th Congress of the European Hematology Association, Vienna, 2022.
    Published • doi: 10.1097/01.HS9.0000849712.10352.58
  9. Giovanni Palladini; Stefan Schönland; Giampaolo Merlini; Paolo Milani; Arnaud Jaccard; Frank Bridoux; Meletios A. Dimopoulos; et al. "Systemic Light Chain Amyloidosis across Europe: Key Outcomes from a Retrospective Study of 4500 Patients". Paper presented in 63rd ASH Annual Meeting and Exposition, Atlanta, 2021.
    10.1182/blood-2021-152675
  10. Sara Peixoto da Silva; Rui Bergantim; Mélanie A. G. Barbosa; Hugo R. Caires; Bárbara Polónia; Jose E. Guimaraes; M. Helena Vasconcelos. "Measurable Residual Disease in Extracellular Vesicles from Bone Marrow and Peripheral Blood of Patients with Multiple Myeloma: A Proof-of-Concept Study". Paper presented in 63rd ASH Annual Meeting and Exposition, Atlanta, 2021.
    10.1182/blood-2021-149398
  11. Rui Bergantim; Luisa Lacerda; Mariana Trigo; Andre Pardal; Marta Henriques; Maria João Cardoso; Pedro Baptista; Fernanda Trigo. "Serum-free light chain and heavy-light chains normalization as markers for negative measurable residual disease in Multiple Myeloma after autologous stem cell transplant". Paper presented in 18th International Myeloma Workshop, Vienna, 2021.
    10.1016/s2152-2650(21)02171-6
  12. Giovanni Palladini, Stefan Schönland, Giampaolo Merlini, Paolo Milani, Arnaud Jaccard, Frank Bridoux, Wilfried Roeloffze. "First Glimpse on Real-World Efficacy Outcomes for 2000 Patients with Systemic Light Chain Amyloidosis in Europe: A Retrospective Observational Multicenter Study By the European Myeloma Network". Paper presented in 64th ASH Annual Meeting & Exposition, Virtual Conference, 2020.
    Published • https://doi.org/10.1182/blood-2020-140708
  13. Silva L; Chorão P; Maia T; Marini C; Bergantim R; Bastos J,; Soares MJ; et al. "Salvage treatment with secong autologous hematopoietic stem cell transplant in the multiple myeloma relapse/refratory setting.". Paper presented in 25th Congress of the European Hematology Association / HemaSphere, Virtual Conference, 2020.
    Published
  14. Chorão P; Maia T; Bergantim R; Aguiar E; Pires JC; Trigo F. "Relapse and progression patterns in multiple myeloma after upfront hematopoietic stem cell transplant". Paper presented in European Bone and Bone Marrow Transplant Meeting - Bone Marrow Transplant, Lisboa, 2019.
    Published • https://doi.org/10.1038/s41409-018-0354-7
  15. Chorão P; Maia T; Bergantim R; Aguiar E; Pires JC; Trigo F; Guimarães JE. "Integration of four colour flow to predict relapse/progression and time to next treatment in multiple myeloma after upfront stem cell transplant". Paper presented in 25th Congress of the European Hematology Association / HemaSphere, Virtual Conference, 2019.
    Published • doi: 10.1097/01.HS9.0000563996.12995.af
  16. Marini, C; Baldaia, A; Chorão, P; Bergantim, R; Aguiar, E; Cancela, J; Trigo, F; Guimarães, J.E. "Fungal Infections in Acute Myeloied Leukemia in the posaconazole era". Paper presented in 25th Congress of the European Hematology Association / HemaSphere, Virtual Conference, 2019.
    Published • doi: 10.1097/01.HS9.0000563400.97711.73
  17. Catarina Geraldes; Adriana Roque; Ana Bela Sarmento-Ribeiro; Cristina João; Maria Leticia Ribeiro; Rui Bergantim; Fernanda Trigo; et al. "Predicting Early Mortality in Multiple Myeloma Patients Treated with Novel Agents". Paper presented in 60th American Society of Hematology Annual Meeting and Exposition, San Diego, 2018.
    10.1182/blood-2018-99-117351
  18. Maia T.; Marini C.; Medeiros P; Bergantim, R.; Aguiar, E; Cancela. J; Trigo, F; Guimarães,JE. "Toxicity and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma". Paper presented in 43rd Annual Meeting of the EBMT - Bone Marrow Transplant, Marseille, 2017.
    Published • https://doi.org/10.1038/bmt.2017.131
  19. Tânia Maia; Carolina Marini; Pedro Medeiros; Rui Bergantim; Eliana Aguiar; Jorge Cancela Pires; Fernanda Trigo. "Toxicity and Benefit of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma". Paper presented in 16th International Myeloma Workshop, New Delhi, 2017.
    10.1016/j.clml.2017.03.243
  20. M.I. Pereira; I. Coelho; M. Neves; R. Bergantim; F. Gomes; P. Lucio; G. Esteves; C. Geraldes; C. João. "A national experience of the efficacy and safety of long-term treatment with Lenalidomide in patients with relapsed Multiple Myeloma". Paper presented in 15th International Myeloma Workshop, Rome, 2015.
    Published • 10.1016/j.clml.2015.07.624
  21. Hugo Seca; Raquel T. Lima; Gabriela M. Almeida; Manuel Sobrinho-Simões; Rui Bergantim; Jose E. Guimaraes; M. Helena Vasconcelos. "Mir-128 and DNA Damage In Acute Myeloid Leukemia". Paper presented in American Society of Hematology 55th Annual Meeting and Exposition, New Orleans, 2013.
    10.1182/blood.v122.21.2533.2533
  22. Rui Bergantim; Eliana Aguiar; Rita Damas; Goncalves Luciana; Juliana Bastos; Teresa Garrido; Diana Goncalves; et al. "Poor Stem Cell Mobilization: incidence and Risk Factors". Paper presented in American Society of Hematology 50th Annual Meeting and Exposition, New Orleans, 2013.
    10.1182/blood.v122.21.5439.5439
  23. Guimarães C, Trigo F, Bergantim R, Guimarães T, Guimarães JE. "Emergence Of Oligoclonal Banding In Patients With Multiple Myeloma After Autologous Stem Cell Transplantation". Paper presented in 16th Congress of the European Hematology Association, London, 2011.
    Published
  24. P. Silva Coelho, I. Carvalhais, R. Pinto, J. Martins, P. Guimarães, T. Melo, R. Bergantim, F. Trigo, JE Guimarães. "Prognostic implications of gene abnormalities in acute myeloid leukaemia with normal karyotype (NK-AML): a single centre experience". Paper presented in 14th Congress of the European Hematology Association, 2009.
    Published
  25. Fernanda Trigo; Rui Bergantim; Ricardo Pinto; Patricia Guimarães; José Eduardo Guimarães. "Immunologic Recovery after Autologous Transplant in Multiple Myeloma and Progression Free Survival". Paper presented in American Society of Hematology 50th Annual Meeting and Exposition, San Francisco, 2008.
    Published • https://doi.org/10.1182/blood.V112.11.4444.4444
Conference paper
  1. Pedro Baptista; Clara Afonso Sanches; Inês Salazar Graça; Marta Henriques et al. "Transplante autólogo em leucemia mielóide aguda com mutação npm1: resultados clínicos e desafios moleculares em 15 anos de experiência". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, 2024.
  2. Manuel Neves; José Freitas; Adriana Roque;Leonor Sarmento;Joana Vieira; Clara Sanchez et al.. "Experiência de vida real portuguesa com daratumumab em mieloma múltiplo em primeira linha e recaída/progressão – DARMMA". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, 2024.
  3. Adriana Roque, Carlos Costa, Manuel Neves, Ana Bela Sarmento-Ribeiro, Rita Gerivaz, Ana Luisa Tomé et al.. "Avaliação da qualidade de vida nos doentes portugueses com mieloma múltiplo e sua relação com os cuidadores – SUB-ANÁLISE DO ESTUDO CARMMA". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, 2024.
  4. Carlos Costa; Adriana Roque; João Santinha; Manuel Neves; Ana Bela Sarmento-Ribeiro; Rita Gerivaz et al.. "Previsão da sobrecarga do cuidador do doente com mieloma múltiplo com modelos de inteligência artificial – análise do estudo multicêntrico CARMMA". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, 2024.
  5. Clara Afonso Sanches; Inês Salazar Graça; Miguel Ângelo Neto; Rita Queirós Pereira et al.. "Impacto do daratumumab na mobilização de progenitores hematopoéticos de sangue periférico no mieloma múltiplo". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, 2024.
  6. Costa, Carlos; Roque, Adriana Isabel; Santinha, João; Neves, Manuel; Sarmento-Ribeiro, Ana Bela; Gerivaz, Rita; Tomé, Ana Luisa; et al. "Predicting Caregiver Burden in Multiple Myeloma: Insights from the Carmma Study Using Machine Learning Models". San Diego, 2024.
    10.1182/blood-2024-199354
  7. Manuel Neves; Carlos BT Costa; Adriana Isabel Roque; Ana Bela Sarmento-Ribeiro; Rita Gerivaz; Ana Tomé; Helena Martins; et al. "Impacto Da Sobrecarga Nos Cuidadores De Doentes Com Mieloma Múltiplo Em Portugal". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Viseu, 2023.
  8. Adriana Roque; Carlos BT Costa; Manuel Neves; Ana Bela Sarmento-Ribeiro; Rita Gerivaz; Ana Tomé; Helena Martins; et al. "Avaliação Do Padrão De Cuidadores Dos Doentes Com Mieloma Múltiplo Em Portugal". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Viseu, 2023.
  9. Rui Bergantim; Joana Vieira; Manuel Neves; Claudia Pedrosa; Eliana Aguiar; Inês Vieira; José Freitas; et al. "Teclistamab no Tratamento de Mieloma Múltiplo Recaído/Recidivante Em Portugal". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Viseu, 2023.
  10. Dina Rochate; Adriana Roque; Cátia Almeida; Mafalda Urbano; Ana Rebelo; Joana Santos; Isabel Mesquita; et al. "Leucemia De Plasmócitos: Estudo Multicêntrico Nacional". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Viseu, 2023.
  11. Inês dos Santos Marques; Cátia Sol; Ana Rita Oliveira; Maria José Soares; Aida Barbosa; Maria Luís Amorim; Mariana Lopes; Eliana Aguiar; Rui Bergantim. "Leucemia Linfoblástica Aguda Ph-Negativa – Avaliação Dos Rearranjos No Domínio Tirosine Kinase Por FISH". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia, Tróia, 2022.
  12. Bergantim R, Mélanie A. G. Barbosa, Sara Peixoto da Silva, Hugo R. Caires, José E. Guimarães, M. Helena Vasconcelos. "Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from the Bone Marrow and Peripheral Blood of Multiple Myeloma Patients: a Proof-of-Concept Study". Paper presented in 1st Meeting of the Portuguese Network on Extracellular Vesicles (PNEV), Porto, 2021.
    Accepted
  13. Chorão P, Soares MJ, Maia T, Marini C, Bastos J, Barbosa A, Aguiar E, Cancela Pires J, Bergantim R, Gomes P, Trigo F. "Ganho 1q21 como factor prognóstico na recaída/progressão precoce após transplante autólogo no mieloma múltiplo". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Braga, 2019.
    Accepted
  14. Maia T, Bergantim R, Aguiar E, Cancela Pires J, Trigo F, Guimarães J E. "third autologous stem cell transplantation as an important treatment option in relapsed multiple myeloma". Paper presented in 3rd EBMT International Transplant Course, Barcelona, 2018.
    Accepted
  15. Maia T, Chorão P, Aguiar E, Bergantim R, Gomes P, Trigo F. "Retrospective analysis of early mortality in a cohort of patients with acute promyelocytic leukemia". Paper presented in 7th International Symposium on Acute Promyelocytic Leukemia, Rome, 2017.
    Accepted
  16. Cristina Joao; Rui Bergantim; Sergio Chacim; Manuel Neves; Celina Afonso; Manuela Bernardo; Henrique Coelho; Cristina Fr. "Tratamento Do Mieloma Múltiplo Em Doentes Com 75 Anos Ou Mais – Estudo Multicêntrico Português". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Espinho, 2016.
    Accepted
  17. Marini C; Maia T; Aguiar E; Bergantim R; Cancela Pires J; Trigo F; Guimarães JE. "Toxicidade do Transplante Autólogo de Células Hematopoiéticas em Idosos com Mieloma Múltiplo". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Espinho, 2016.
    Accepted
  18. Bastos J, Bergantim R, Soares MJ, Barbosa A, Gomes P, Trigo F, Guimaraes JE. "Padrões atípicos de imunofixação sérica após autotransplante de progenitores hematopoiéticos em doentes com Mieloma Múltiplo". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Figueira da Foz, 2015.
    Accepted
  19. Pereira MI, Coelho I, Neves M, Bergantim R, Gomes F, Lucio P, Esteves G, Geraldes C, João C. "Eficácia e segurança da utilização prolongada de lenalidomida em doentes com Mieloma Múltiplo em recidiva: uma experiencia nacional". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Figueira da Foz, 2015.
    Accepted
  20. Bergantim R, Aguiar E, Garrido T, Damas R, Carreia A, Bastos J, Gonçalves D, Conçalves L, Carneiro A, Principe F, Trigo. "Factores condicionantes da mobilização de progenitores hematopoiéticos". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Porto, 2013.
    Accepted
  21. Melo T, Almeida CF, Marques C, Barbot J, Ferreira F, Martins J, Bergantim R, Botelho F, Sousa H, Fernandes S, Teles MJ,. "Diagnóstico imunofenotípico de esferocitose hereditária: utilidade na prática clínica". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Troia, 2010.
    Accepted
  22. Chacim L, Leite LC, Ferreira IC, Pereira D, Moreira C, Mariz JM, Esteves G, Alves do Carmo J, Fernandes T, Botelho de So. "MPT em doentes com Mieloma Múltiplo não elegíveis para transplante: estudo multicêntrico". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Troia, 2010.
    Accepted
  23. Torres AL, Bergantim R, Costa V, Norton L. "Linfoma de Hodgkin num Centro de Referência: casuistica de 2000-2009". Paper presented in 11º Pediatrics Portuguese Society, Funchal, 2010.
    Accepted
  24. Bergantim R, Guimarães T, Almeida M, Oliva T, Costa V, Maia I, Norton L. "Leucemia Aguda Linfoblástica da criança, 10 anos de experiência com o protocolo 58951 EORTC". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Troia, 2010.
    Accepted
  25. Bergantim R, Carvalhais I, Trigo F, Guimarães JE. "Profilaxia de infecções fúngicas invasivas em doentes neutropénicos". Paper presented in VII Reunion of Young Hematologists, Óbidos, 2009.
    Accepted
  26. Geraldes C, Lírio E, Bergantim R, Tomaz J, Abecassis M, Príncipe F, Sousa I.. "Plerixafor/G-CSF como regime de mobilização de progenitores hematopoiéticos – experiencia nacional com os primeiros 20 doentes". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Troia, 2009.
    Accepted
  27. Bergantim R, Carvalhais I, Trigo F, Guimarães JE. "Profilaxia de infecções fúngicas invasivas em doentes neutropénicos". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Troia, 2009.
    Accepted
  28. Trigo F, Pinto R, Bergantim R, Guimarães, Guimarães JEG, Marques C. "Mieloma Múltiplo: reconstituição imunológica após auto-transplante de células progenitoras hematopieticas e ‘progression free survival". Paper presented in Annual Reunion of the Portuguese Society of Hematology, Torres Vedras, 2008.
    Accepted
Conference poster
  1. Adriana Roque, Carlos Costa, Manuel Neves, Ana Bela Sarmento-Ribeiro, Rita Gerivaz, Ana Luisa Tome; Helena Martins, Joan; et al.. "Quality of life of Portuguese multiple myeloma patients and its relationship with caregivers". Paper presented in 29th Congress of the European Hematology Association, Madrid - Spain, 2024.
    https://doi.org/10.1002/hem3.104
  2. Carlos BT Costa; Manuel Neves; Adriana Isabel Roque; Ana Bela Sarmento-Ribeiro; Rita Gerivaz; Ana Tomé; Sofia Afonso; et al. "Assessment of Multiple Myeloma-Related Burden on Caregivers - a Portuguese National Study". Paper presented in 67th American Society of Hematology (ASH) Annual Meeting and Exposition, San Diego - USA, 2023.
    10.1182/blood-2023-182698
  3. Rui Bergatim; Catarina Geraldes; Cristina João; Paulo Lúcio; Manuel Neves; Fernanda Trigo; Miguel Pereira Ventura; Diogo Ramos. "Evolution of the multiple myeloma treatment landscape in Portugal: a 5-year longitudinal analysis of treatment patterns in nationwide clinical practice". Paper presented in International Myeloma Society Meeting, Athens - Greece, 2023.
    10.1016/s2152-2650(23)01796-2
  4. Rui Bergatim; José Guilherme Freitas; Cristina Gonçalves; Helena Martins; Herlander Marques; Henrique Coelho; Patrícia Seabra; et al. "Clinical and sociodemographic characterization of multiple myeloma patients with symptomatic relapse and/or refractory disease under treatment in Portugal: an observational, multicenter study". Paper presented in International Myeloma Society Meeting, Athens - Greece, 2023.
    10.1016/s2152-2650(23)01853-0
  5. Catarina Geraldes; Manuel Neves; Rui Bergantim; Fernando Leal da Costa. "Simulating the impact of treatment sequences in health outcomes of patients with multiple myeloma ineligible for autologous stem cell transplant". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia - Tróia, Portugal, 2022.
  6. Rui Bergantim; André Caetano;  Francisco Ferreira Silva; Isabel Tavares;  Manuela Fiuza; Graça Esteves. "Diagnosis and referral of AL Amyloidosis in Portugal - results from a delphi panel". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia - Tróia, Portugal, 2022.
  7. Marta Henriques; Rui Bergantim;  Fátima Ferreira; Fernanda Trigo. "Ibrutinib no tratamento de doentes com Leucemia Linfocítica Crónica - experiência de um centro". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia - Tróia, Portugal, 2022.
  8. Marta Henriques; Pedro Chorão; Joaquim Monteiro; Pedro Baptista; Juliana Bastos; Ricardo Pinto; Rui Bergantim; Fátima Ferreira;  Fernanda Trigo . "Neutropenia febril em doentes hemato-oncológicos submetidos a transplante autólogo de progenitores hematopoiéticos e a realização de tc torácica". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia - Tróia, Portugal, 2022.
  9. Bergantim, Rui; Peixoto da Silva, Sara; Polónia, Bárbara; Barbosa, Mélanie A. G.; Caires, Hugo R.; Guimarães, José E.; Vasconcelos, M. Helena. "Studying microRNAs from Extracellular Vesicles as potential biomarkers in liquid biopsies of Multiple Myeloma patients (co-first author; presented by Rui Bergantim)". Paper presented in 19th International Myeloma Society Annual Meeting, 2022.
  10. Bergantim, Rui; Peixoto da Silva, Sara; Pereira, Joana; Pinto, Vanessa; Sousa, Diana; Matthiesen, Rune; Guimarães, José E.; Vasconcelos, M. Helena. "Identifying microRNAs as potential biomarkers of drug resistance in Multiple Myeloma patients: proof-of-concept study (co-author; presented by Rui Bergantim)". Paper presented in 19th International Myeloma Society Annual Meeting, 2022.
  11. Bergantim R, Sara Peixoto da Silva, Bárbara Polónia, Mélanie A. G. Barbosa, Hugo R. Caires, José E. Guimarães, M. Helena. "Identifying microRNAs as potential biomarkers of drug resistance in Multiple Myeloma patients: proof-of-concept study.". Paper presented in International Myeloma Society Meeting. Los Angeles, USA., 2022.
  12. Bergantim R, Sara Peixoto da Silva, Joana Pereira, Vanessa Pinto, Diana Sousa, Rune Matthiesen, José E. Guimarães, M. He. "Identifying microRNAs as potential biomarkers of drug resistance in Multiple Myeloma patients: proof-of-concept study.". Paper presented in International Myeloma Society Meeting. Los Angeles, USA., 2022.
  13. Bergantim, Rui; Peixoto da Silva, Sara; Pereira, Joana; Pinto, Vanessa; Sousa, Diana; Matthiesen, Rune; Guimarães, José Eduardo; Vasconcelos, M. Helena. "Circulating microRNAs as drug resistance biomarkers in Multiple Myeloma patients (co-author; presented by Rui Bergantim)". Paper presented in 5th Annual Meeting STRATAGEM COST Action, 2022.
  14. Bergantim R, Sara Peixoto da Silva, Joana Pereira, Vanessa Pinto, Diana Sousa, Rune Matthiesen, José E. Guimarães, M. He. "Circulating microRNAs as drug resistance biomarkers in Multiple Myeloma patients.". Paper presented in 5th STRATAGEM Annual Meeting on New diagnostic and therapeutic tools against multidrug resistant tumors. Coimbra, Portugal., 2022.
  15. Baptista P, Henriques M, Pardal AA, Monteiro P, Soares MJ, Barbosa A, Gomes P, Bergantim R, Aguiar E, Pires JC, Trigo F. "Cumulative effect of cytogenetic hits on multiple myeloma relapse after autologous stem cell transplant". Paper presented in 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) - Virtual Conference, 2022.
  16. Baptista P, Henriques M, Pardal AA, Monteiro P, Machado I, Teixeira S, Gonçalves L, Bergantim R, Aguiar E, Pires JC, Tri. "No added benefit from high-dose cyclophospamide stem cell mobilization in multiple myeloma in first complete remission after bortezomib-based induction therapy". Paper presented in 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) - Virtual Conference, 2022.
  17. Henriques M, Chorão P, Baptista P, Pardal AA, Monteiro P, Soares MJ, Barbosa A, Gomes P, Bergantim R, Aguiar E, Pires J. "Loss of 13p as an independent prognostic factor for early relapse after first line autologous stem cell transplant in multiple myeloma". Paper presented in 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) - Virtual Conference, 2022.
  18. Henriques M, Baptista P, Medeiros P, Marini C, Bastos J, Pinto AL, Bergantim R, Trigo F. "Active SARS-CoV-2 infection on the day before autologous stem cell transplant in a patient with multiple myeloma". Paper presented in 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) - Virtual Conference, 2022.
  19. Henriques M, Chorão P, Monteiro J, Baptista P, Bastos J, Pinto R, Bergantim R, Trigo F. "Tomografia computadorizada torácica na investigação da neutropenia febril em doentes com neoplasias hematológicas submetidos a transplante autólogo de progenitores hematopoiéticos". Paper presented in Perspectivas em Oncologia X, 2022.
  20. Bergantim, Rui; Peixoto da Silva, Sara; Polónia, Bárbara; Barbosa, Mélanie A. G.; Caires, Hugo R.; Guimarães, José E.; Vasconcelos, M. Helena. Corresponding author: Vasconcelos, M. Helena. "Detection of Multiple Myeloma Biomarkers in Extracellular Vesicles from Peripheral Blood and Bone Marrow patients samples (co-author; presented by Rui Bergantim)". Paper presented in Reunião Híbrida Sociedade Portuguesa de Hematologia 2021 (SPH 2021), 2021.
  21. Bergantim R, Sara Peixoto da Silva, Bárbara Polónia, Mélanie A. G. Barbosa, Hugo R. Caires, José E. Guimarães, M. Helena. "Detection of Multiple Myeloma biomarkers in extracellular vesicles from peripheral blood and bone marrow patient’s samples". Paper presented in Reunião Anual da Sociedade Portuguesa de Hematologia. Espinho, Portugal., 2021.
  22. Baptista P, Henriques M, Pardal AA, Monteiro P, Soares MJ, Barbosa A, Gomes P, Bergantim R, Aguiar E, Pires JC, Trigo F. "Efeito cumulativo dos hits citogeneticos na recaida apos transplante autologo em mieloma multiplo". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Espinho, Portugal, 2021.
  23. Pardal AA, Baptista P, Henriques M, Monteiro P, Silva PR, Aguiar E, Pires JC, Bergantim R, Trigo F. "Caracterização e avaliação da manutenção com lenalidomida no mieloma após transplante autologo de progenitores hematopoiétiocs". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Espinho, Portugal, 2021.
  24. Henriques M, Baptista P, Pardal AA, Monteiro P, Soares MJ, Barbosa A, Gomes P, Bergantim R, Aguiar E, Pires JC, Trigo F. "Factores de recaída precoce em doentes com MM elegíveis para transplante autologo de progenitores hematopoiéticos". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Espinho, Portugal, 2021.
  25. Bergantim, Rui; Barbosa, Mélanie A. G.; Peixoto da Silva, Sara; Caires, Hugo R.; Guimarães, José E.; Vasconcelos, M. Helena. Corresponding author: Vasconcelos, M. Helena. "Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from the Bone Marrow and Peripheral Blood of Multiple Myeloma Patients: a Proof-of-Concept Study (co-author; work presented in a Speed Talk)". Paper presented in First Meeting of the Portuguese Network on Extracellular Vesicles (PNEV), 2021.
  26. Pereira FM, Maia T, Gomes M, Chorão P, Gomes P, Amorim ML, Aguiar E, Bergantim R, Trigo F. "Leucaferese na Leucemia Mielóide Aguda Hiperleucocitária- estudo retrospectivo". Paper presented in Annual reunion of the Portuguese Society of Hematology - Virtual Conference, 2020.
  27. Maia T, Bergantim R, Aguiar E, Cancela Pires J, Ricca L, Trigo F. "Eficácia e segurança dos esquemas de mobilização de progenitores hematopoiéticos em doentes com mieloma múltiplo". Paper presented in Annual reunion of the Portuguese Society of Hematology - Virtual Conference, 2020.
  28. Maia T, Pereira FM, Soares MJ, Silva L, Chorão P, Marini C, Cancela Pires J, Aguiar E, Bergantim R, Trigo F. "Impacto da t(11;14) na sobrevida global de doentes com mieloma múltiplo". Paper presented in Annual reunion of the Portuguese Society of Hematology - Virtual Conference, 2020.
  29. Cátia Sol Reis, Patrícia Silva, Eliana Aguiar, Rui Bergantim, Inês Carvalhais, Ana Carneiro, Jorge Cancela Pires, Fernan. "Macroglobulinemia Waldenström – a single centre experience". Paper presented in 2nd How to Diagnose and Treat LYMPHOMA - European School of Haematology - E-conference., 2020.
  30. Silva L, Chorão P, Maia T, Marini C, Bergantim R, Bastos J, Soares MJ, Barbosa A, Carneiro A, Aguiar E, Cancela Pires J,. "Salvage Treatment with Second Autologous Hematopoietic Stem Cell Transplant in the Multiple Myeloma Relapse/Refractory Setting". Paper presented in 25th Congress of the European Hematology Association - Virtual, 2020.
  31. Baptista P, Chorão P, Pinto R, Bergantim R, Trigo F. "A 55-year-old man with a diagnosis with blastoid mantle cell lymphoma admitted with dyspnea and disorientation". Paper presented in 2nd How to diagnose and treat lymphoma, EHA - Virtual Conference, 2020.
  32. Silva L, Chorão P, Maia T, Marini C, Bergantim R, Bastos J, Soares MJ, Barbosa A, Carneiro A, Aguiar E, Cancela Pires J,. "Tratamento de resgate com segundo transplante autólogo de progenitores hematopoiéticos no Mieloma Múltiplo". Paper presented in Perspectivas em Oncologia VIII - Porto, Portugal, 2020.
  33. Bergantim R; Roque A; Geraldes C; Maia T; Tavares I; Dantas C; Gonçalves C, Pereira SG; Matos Silva H; Coelho H; Trigo F. "Gamapatia Monoclonal de Significado Renal: a prática clínica em Portugal". Paper presented in Annual reunion of the Portuguese Society of Hematology - Braga, Portugal, 2019.
  34. Chorão P, Maia T, Bergantim R, Aguiar E, Pires JC, Trigo F, Guimarães JE. "Integration of four colour flow to predict relapse/progression and time to next treatment in multiple myeloma after upfront stem cell transplant". Paper presented in 24th Congress of the European Hematology Association - Amsterdan, Netherlands, 2019.
  35. Maia T, Bergantim R, Tavares I, Pestana R, Príncipe F, Trigo F. "Monoclonal Gammopathy of Renal Significance Three Clinical Cases". Paper presented in 5th World Congresses on Controversies in Multiple Myeloma (COMy) - Paris, France, 2019.
  36. Chorão P, Maia T, Bergantim R, Aguiar E, Pires JC, Trigo F, Guimarães JE. "Impacto dos plasmócitos anormais ao dia 100 após transplante autólogo de progenitores hematopoiéticos". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Algarve, Portugal, 2018.
  37. Bergantim R; Geraldes C; Roque A; Esteves G; Maia T; João C; Trigo F. "Amiloidose AL em Portugal". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Algarve, Portugal, 2018.
  38. Chorão P, Tânia Maia. Rui Bergantim, Eliana Aguiar, Jorge Cancela Pires, Fernanda Trigo, José E. Guimarães. "Relapse and progression patterns in multiple myeloma after upfront hematopoietic stem cell transplant". Paper presented in Annual Meeting of the European Group for Blood and Marrow Transplantation – Lisbon, Portugal, 2018.
  39. Chorão P; Tânia Maia; Rui Bergantim; Eliana Aguiar; Jorge Cancela Pires; Fernanda Trigo; José E. Guimarães. "Análise retrospectiva de padrões de recaída/progressão em mieloma múltiplo após transplante autólogo de progenitores hematopoiéticos em primeira linha". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Algarve, Portugal, 2017.
  40. Bettencourt Medeiros P; Rui Bergantim; Maria José Soares; Fernanda Trigo; José Eduardo Guimarães. "Prognostic factors and impact of chemotherapy and stem cell transplantation in patients with plasma cell leukemia". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Algarve, Portugal, 2017.
  41. Maia T, Chorão P, Bergantim R, Aguiar E, Gomes P, Trigo F, Guimarães JE. "Mortalidade precoce na leucemia promielocitica aguda – análise retrospectiva de dados da vida real". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Algarve, Portugal, 2017.
  42. Pinto V, Bergantim R, José E. Guimarães, Hugo Seca, M. Helena Vasconcelos. "Optimizing protocols for the detection of microRNAs as biomarkers of drug resistance in Extracellular Vesicles isolated from the plasma of multiple myeloma patients.". Paper presented in 24th Porto Cancer Meeting. Porto, Portugal, 2017.
  43. Maia T, Marini C, Medeiros P, Bergantim R, Aguiar E, Pires J, Trigo F, Guimarães JE. "Safety and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma". Paper presented in Annual Meeting of the European Group for Blood and Marrow Transplantation 2017 – Marseille, France, 2017.
  44. Maia T, Bergantim R, Aguiar E, Pires J, Trigo F. "Patients with AL Amyloidosis in Tertiary Hospital between 2014-2017, retrospective study". Paper presented in Controversies in Multiple Myeloma (CoMY) - Paris, France, 2017.
  45. Maia T, Marini C, Medeiros P, Bergantim R, Aguiar E, Pires J, Trigo F, Guimarães JE. "Safety and 6 Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma". Paper presented in International Myeloma Workshop – New Delhi, India, 2017.
  46. Pinto, Vanessa; Bergantim, Rui; Guimarães, J. E; Seca, Hugo; Vasconcelos, M. Helena. "Comparing protocols for Extracellular Vesicles isolation from the plasma of patients with multiple myeloma". Paper presented in 5th i3S Annual Meeting, 2016.
  47. Pinto V, Rui Bergantim, José Eduardo Guimarães, Hugo Seca Teixeira, Helena Vasconcelos. "Comparison of extracellular vesicles isolation protocols from the plasma of patients with multiple myeloma: size characterization, expression of ev markers and micrornas". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Espinho, Portugal, 2016.
  48. Maia T; Rui Bergantim; Henrique Costa; Fernanda Trigo; José Eduardo Guimarães. "Miopatia nemalínica esporádica do adulto associada a MGUS, um equivalente a mieloma múltiplo?". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Espinho, Portugal, 2016.
  49. Bastos J, Bergantim R, Trigo F, Guimaraes JE. "Atypical serum immunofixation patterns after autologous stem cell transplantation in patients with multiple myeloma". Paper presented in European Bone and Bone Marrow Transplant Meeting - Valencia, Spain, 2016.
  50. Bergantim R, Juliana Bastos, Maria José Soares, Bruno Carvalho, Pedro Soares, Cristina Marques, Jennifer Costa, Fernanda. "Central nervous system relapse in multiple myeloma after autologous stem cell transplant". Paper presented in Janssen Hematology Meeting - Figueira da Foz, Portugal, 2016.
  51. Bastos J, Bergantim R, Soares MJ, Gomes P, Trigo F. "Prognostic impact of cytogenetic abnormalities at diagnosis in multiple myeloma". Paper presented in 2015 Lymphoma & Myeloma, an international congress on Hematologic Malignancies - New York, USA, 2015.
  52. Bastos J, Bergantim R, Soares MJ, Gomes P, Trigo F. "Application of the Revised International Staging System for risk stratification in Multiple Myeloma". Paper presented in 2015 Lymphoma & Myeloma, an international congress on Hematologic Malignancies - New York, USA, 2015.
  53. Pereira MI, Coelho I, Neves M, Bergantim R, Gomes F, Lucio P, Esteves G, Geraldes C, João C. "A national experience of the efficacy and safety of long term treatment with lenalidomide in patients with relapsed Multiple Myeloma". Paper presented in 5th International Myeloma Workshop - Rome, Italy, 2015.
  54. Bergantim R, Esteves G, Trigo F, Coelho I, João C, Parreira J, Castro M, Trindade MC, Macedo A, Geraldes C, Sarmento AB,. "Mieloma Múltiplo em doentes jovens - apresentação clínica e abordagem terapêutica". Paper presented in Annual reunion of the Portuguese Society of Haematology - Évora, Portugal, 2014.
  55. Bastos J, Afonso S, Aguiar E, Badior M, Araujo J, Bergantim R, Trigo F, Principe F, Guimaraes JE. "Leucemia Mieloide Aguda no Idoso". Paper presented in Annual reunion of the Portuguese Society of Hematology - Évora, Portugal, 2014.
  56. Seca, Hugo; Raquel T. Lima; Almeida, Gabriela M.; Sobrinho-Simões, M. A.; Bergantim, Rui; Guimarães, José E.; Vasconcelos, Helena M.. "miR-128 increases DNA damage in acute myeloid leukemia cells". Paper presented in I3S Scientific Retreat 2014, 2014.
  57. Bergantim R, Parreira J, João C, Trigo F, Lopes R, Geraldes C, Teixeira A, Chacim S, Mariz JM, Macedo A, Marques H, Gonç. "Uso de bortezomib na quimioterapia de indução em doentes com Mieloma Múltiplo submetidos a transplante autólogo de progenitores hematopoiéticos - uma perspectiva nacional". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Porto, Portugal, 2013.
  58. Seca H, Lima R, Almeida G, Sobrinho-Simões M, Bergantim R, Guimares JE, Vasconcelos MH. "Mir-128 induces DNA damage and sensitizes AML cells to etoposide and doxorubicin". Paper presented in Annual reunion of the Portuguese Society of Hematology - Porto, Portugal, 2013.
  59. Rui Bergantim, Eliana Aguiar, Fernanda Trigo, Ana Carneiro, Fernando Príncipe, José Eduardo Guimarães. "Transplante autólogo de progenitores hematopoiéticos como terapêutica de pós- remissão na leucemia aguda mieloide". Paper presented in Annual Reunion of the Portuguese Society of Hematology – Porto, Portugal, 2012.
  60. Bergantim R, Aguiar E, Garrido T, Trigo F, Guimarães JE. "Impact of posaconazole prophylaxis in patients with acute myeloid leukemia and high risk myelodisplastic syndromes". Paper presented in 2nd World Congress on Controversies in Hematology (COHEM) – Barcelona, Spain, 2012.
  61. Bergantim R, Aguiar E, Trigo F, Principe F, Guimarães JE. "Autologous Stem Cell Transplantation for Acute Myeloid Leukemia as post-remission therapy". Paper presented in International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) – Berlin, Germany, 2011.
  62. Bergantim R, Aguiar E, Trigo F, Principe F, Guimarães JE. "Impact of patient’s responses before and after Autologous Stem Cell Transplant on Multiple Myeloma". Paper presented in International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) – Berlin, Germany, 2011.
  63. Bergantim R, Andrade J, Duarte R, Brochado M, Pires J, Príncipe F, Guimarães JE. "Uso de romiplostim na Trombocitopenia imune crónica refractária". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Troia, Portugal, 2010.
  64. Bergantim R, Badior M, Trifo F, Guimarães JE. "Mucormicose como infecção fúngica emergente em doentes hemato-oncológicos". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Troia, Portugal., 2010.
  65. Bergantim R, Costa E, Santo ES, Tamary H, Barbot J. "Portuguese monozygotic twin sisters with congenital dyserythropoietic anaemia type I and mild iron overload". Paper presented in ESH-EHA Scientifc Workshop Innovative Therapies for Red Cell and Iron Related Disorders – Cascais, Portugal, 2010.
  66. Bergantim R, Pinto R, Trigo F, Guimarães JE. "The impact of polyclonal immunoglobulin recovery after autologous stem cell transplant in multiple myeloma". Paper presented in 36th Annual Meeting of the European Group for Blood and Marrow Transplantation – Vienna, Austria, 2010.
  67. Ferreira E., Gavina C., Vasconcelos M., Bergantim R. "Fibrilação Auricular – da doença valvular ao linfoma". Paper presented in VII Internal Medicine Felllows Congress VII – Algarve, Portugal, 2010.
  68. Pinto R, Bergantim R, Guimaraes P, Trigo F, Guimarães JEG. "Leucemia Aguda de Fenótipo Misto em adultos: revisão da experiência de 7 anos". Paper presented in Annual Reunion of the Portuguese Society of Hematology - Troia, Portugal., 2009.
  69. Bergantim R, Carvalhais I, Trigo F, Guimarães JE. "Antifungal prophylaxis in acute myeloid leukemia and high-risk myelodysplastic patients: a single center experience". Paper presented in 4th Trends in Medical Micology – Athens, Greece, 2009.
Journal article
  1. Bergantim, Rui; Peixoto da Silva, Sara; Pinto, Vanessa; Pereira, J. M.; Sousa, Diana; fernanda trigo; Matthiesen, Rune; José Eduardo Guimarães; Vasconcelos, M. Helena. "MicroRNA-665 and its potential role in drug response and survival outcomes in Multiple Myeloma: a preliminary study". Frontiers in Pharmacology 16 (2025): https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2025.1465814/abstract.
    Published
  2. Baptista, Pedro; Henriques, Marta; Miranda, Mariana; Bergantim, Rui; Trigo, Fernanda. "Clostridium perfringens Sepsis Complicated by Hepatic Abscess Following Intensive Chemotherapy in Mixed-Phenotype Acute Leukemia". Cureus (2025): https://doi.org/10.7759/cureus.77122.
    10.7759/cureus.77122
  3. Neves, Manuel; Gerivaz, Rita; Esteves, Graça; Bergantim, Rui; Ferreira, Gisela; Coelho, Henrique; Afonso, Celina; et al. "Prevalence of measurable residual disease in patients with refractory/relapsed multiple myeloma who reached complete response: a cross-sectional multicentric study". Frontiers in Hematology 3 (2024): https://doi.org/10.3389/frhem.2024.1480120.
    10.3389/frhem.2024.1480120
  4. Bergantim, Rui; Geraldes, Catarina; João, Cristina; Lúcio, Paulo; Neves, Manuel; Trigo, Fernanda; Pedrosa, Hugo; et al. "The evolving treatment landscape of multiple myeloma in Portugal: A nation-wide retrospective cohort study of real-world clinical practice". eJHaem (2024): http://dx.doi.org/10.1002/jha2.1035.
    10.1002/jha2.1035
  5. Geraldes, C.; Neves, M.; Bergantim, R.; Silva, C.; Leal da Costa, F.. "Improving Health Outcomes Through Treatment Sequencing Optimization in Multiple Myeloma: A Simulation Model in Transplant-Ineligible Patients". Cancer Reports 7 10 (2024): http://dx.doi.org/10.1002/cnr2.70027.
    10.1002/cnr2.70027
  6. Pereira, Rita; Bergantim, Rui. "An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis". International Journal of Molecular Sciences 25 9 (2024): 4996. http://dx.doi.org/10.3390/ijms25094996.
    10.3390/ijms25094996
  7. Salmanton-García, Jon; Marchesi, Francesco; Farina, Francesca; Weinbergerová, Barbora; Itri, Federico; Dávila-Valls, Julio; Martín-Pérez, Sonia; et al. "Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022". eClinicalMedicine 71 (2024): 102553. http://dx.doi.org/10.1016/j.eclinm.2024.102553.
    10.1016/j.eclinm.2024.102553
  8. Aiello, Tommaso Francesco; Salmanton-Garcia, Jon; Marchesi, Francesco; Weinbergerova, Barbora; Glenthoj, Andreas; Van Praet, Jens; Farina, Francesca; et al. "Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA Registry". Haematologica (2024): http://dx.doi.org/10.3324/haematol.2023.284678.
    10.3324/haematol.2023.284678
  9. Geraldes, Catarina; Roque, Adriana; Sarmento-Ribeiro, Ana Bela; Neves, Manuel; Ionita, Alina; Gerivaz, Rita; Tomé, Ana; et al. "Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma". Frontiers in Oncology 14 (2024): http://dx.doi.org/10.3389/fonc.2024.1282300.
    10.3389/fonc.2024.1282300
  10. Lahmer, Tobias; Salmanton-García, Jon; Marchesi, Francesco; El-Ashwah, Shaimaa; Nucci, Marcio; Besson, Caroline; Itri, Federico; et al. "Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey". Infection 52 3 (2024): 1125-1141. http://dx.doi.org/10.1007/s15010-023-02169-7.
    10.1007/s15010-023-02169-7
  11. Jaccard, Arnaud; Bridoux, Frank; Roeloffzen, Wilfried; Minnema, Monique C.; Bergantim, Rui; Hájek, Roman; João, Cristina; et al. "Healthcare resource utilization and cost-of-illness in systemic light chain (AL) amyloidosis in Europe: results from the real-world, retrospective EMN23 study". Clinical Lymphoma Myeloma and Leukemia (2024): http://dx.doi.org/10.1016/j.clml.2024.01.013.
    In press • 10.1016/j.clml.2024.01.013
  12. Carujo, António; Ferreira, Luís; Bergantim, Rui; Santos Silva, André; Vasconcelos, António Ludgero. "Relapsing COVID-19 in a Patient With Non-Hodgkin Lymphoma on Chemotherapy". Cureus (2023): http://dx.doi.org/10.7759/cureus.49974.
    10.7759/cureus.49974
  13. Musto, Pellegrino; Salmanton-García, Jon; Sgherza, Nicola; Bergantim, Rui; Farina, Francesca; Glenthøj, Andreas; Cengiz Seval, Guldane; et al. "Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry". Hematological Oncology 42 1 (2023): http://dx.doi.org/10.1002/hon.3240.
    10.1002/hon.3240
  14. Rossi, Giuseppe; Salmanton-García, Jon; Cattaneo, Chiara; Marchesi, Francesco; Dávila-Valls, Julio; Martín-Pérez, Sonia; Itri, Federico; et al. "Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings". International Journal of Infectious Diseases 137 (2023): 98-110. http://dx.doi.org/10.1016/j.ijid.2023.10.013.
    10.1016/j.ijid.2023.10.013
  15. Costa, Carlos BT; Neves, Manuel; Roque, Adriana Isabel; Sarmento-Ribeiro, Ana Bela; Gerivaz, Rita; Tomé, Ana; Afonso, Sofia; et al. "Assessment of Multiple Myeloma-Related Burden on Caregivers - a Portuguese National Study". Blood 142 Supplement (2023): 3335-3335. http://dx.doi.org/10.1182/blood-2023-182698.
    10.1182/blood-2023-182698
  16. Vieira, Cláudia; Bergantim, Rui; Madureira, Elsa; Barroso, Juan C.M.; Labareda, Miguel; Parreira, Sara T.; Castro, Ana; Macedo, Ana; Custódio, Sandra. "Portuguese consensus on the prevention and treatment of nausea and vomiting induced by cancer treatments". Porto Biomedical Journal 8 5 (2023): http://dx.doi.org/10.1097/j.pbj.0000000000000234.
    10.1097/j.pbj.0000000000000234
  17. Bergantim, Rui; Caetano, André; Silva, Francisco F.; Tavares, Isabel; Ferreira, Manuela; Jaime, Ana R.; Esteves, Graça V.. "Diagnosis and referral of patients with AL amyloidosis in Portugal: results from a Delphi panel". Porto Biomedical Journal 8 5 (2023): http://dx.doi.org/10.1097/j.pbj.0000000000000231.
    10.1097/j.pbj.0000000000000231
  18. João, Cristina; Bergantim, Rui; Santos, Joana; Afonso, Celina; Bernardo, Paulo; Coelho, Henrique; Costa, Carlos; et al. "Recomendações do Grupo Português do Mieloma Múltiplo para Tratamento do Mieloma Múltiplo". Acta Médica Portuguesa 36 7-8 (2023): 517-526. http://dx.doi.org/10.20344/amp.19037.
    Published • 10.20344/amp.19037
  19. Bergantim, Rui; Chacim, Sérgio; Monteiro, Alexandra; Macedo, Ana M.; Rodrigues, Gonçalo M. C.; da Silva, Maria Gomes. "Waldenström Macroglobulinemia diagnosis, risk assessment and treatment in Portugal - results from a Delphi-like Panel". Frontiers in Hematology 2 (2023): http://dx.doi.org/10.3389/frhem.2023.1203369.
    10.3389/frhem.2023.1203369
  20. Salmanton-García, Jon; Marchesi, Francesco; Gomes da Silva, Maria; Farina, Francesca; Dávila-Valls, Julio; Bilgin, Yavuz M.; Glenthøj, Andreas; et al. "Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry". eClinicalMedicine 58 (2023): 101939. http://dx.doi.org/10.1016/j.eclinm.2023.101939.
    10.1016/j.eclinm.2023.101939
  21. Palladini, Giovanni; Schönland, Stefan; Merlini, Giampaolo; Milani, Paolo; Jaccard, Arnaud; Bridoux, Frank; Dimopoulos, Meletios A.; et al. "The management of light chain (AL) amyloidosis in Europe: clinical characteristics, treatment patterns, and efficacy outcomes between 2004 and 2018". Blood Cancer Journal 13 1 (2023): http://dx.doi.org/10.1038/s41408-023-00789-8.
    10.1038/s41408-023-00789-8
  22. Marchetti, Monia; Salmanton-García, Jon; El-Ashwah, Shaimaa; Verga, Luisa; Itri, Federico; Rácil, Zdenek; Dávila-Valls, Julio; et al. "Outcomes of SARS-CoV-2 infection in Ph-neg chronic myeloproliferative neoplasms: results from the EPICOVIDEHA registry". Therapeutic Advances in Hematology 14 (2023): 204062072311547. http://dx.doi.org/10.1177/20406207231154706.
    10.1177/20406207231154706
  23. Cattaneo, Chiara; Salmanton-García, Jon; Marchesi, Francesco; El-Ashwah, Shaimaa; Itri, Federico; Weinbergerová, Barbora; Gomes Da Silva, Maria; et al. "Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey". Cancers 14 22 (2022): 5530. http://dx.doi.org/10.3390/cancers14225530.
    10.3390/cancers14225530
  24. Bergantim, Rui; Peixoto da Silva, Sara; Polónia, Bárbara; Barbosa, Mélanie A. G.; Albergaria, André; Lima, Jorge; Caires, Hugo R.; Guimarães, José E.; Vasconcelos, M. Helena. "Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients—A Proof of Concept". International Journal of Molecular Sciences 23 22 (2022): 13686. http://dx.doi.org/10.3390/ijms232213686.
    10.3390/ijms232213686
  25. Catarina Oliveira-Silva; Nídia Marques; Ana Pinho; Rui Poínhos; Rui Bergantim; Ana Teresa Nunes; Susana Sampaio; et al. "Lessons from Four Decades of Systemic Amyloidosis with Renal Involvement". Nephron (2022): https://doi.org/10.1159/000525675.
    10.1159/000525675
  26. Faria, Monteiro, Joaquim; Rita, Damas; Rui, Bergantim; Fernanda, Trigo. "Optimum Methotrexate Exposure in Patients with Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review". Therapeutic Drug Monitoring Publish Ah (2022): http://dx.doi.org/10.1097/ftd.0000000000001022.
    10.1097/ftd.0000000000001022
  27. Lamure, Sylvain; Salmanton-García, Jon; Robin-Marieton, Elena; Jaksic, Ozren; Kohn, Milena; Marchesi, Francesco; Marchetti, Monia; et al. "COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey". Blood Advances 6 13 (2022): 3870-3874. http://dx.doi.org/10.1182/bloodadvances.2022007357.
    10.1182/bloodadvances.2022007357
  28. Blennow, Ola; Salmanton-García, Jon; Nowak, Piotr; Itri, Federico; Van Doesum, Jaap; López-García, Alberto; Farina, Francesca; et al. "Outcome of infection with omicron SARS-CoV -2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report". American Journal of Hematology 97 8 (2022): http://dx.doi.org/10.1002/ajh.26626.
    10.1002/ajh.26626
  29. Marchesi, Francesco; Salmanton-García, Jon; Emarah, Ziad; Piukovics, Klára; Nucci, Marcio; López-García, Alberto; Rácil, Zdenek; et al. "COVID-19 in adult acute myeloid leukemia patients: a long-term followup study from the European Hematology Association survey (EPICOVIDEHA)". Haematologica (2022): http://dx.doi.org/10.3324/haematol.2022.280847.
    10.3324/haematol.2022.280847
  30. Marchesi, Francesco; Salmanton-García, Jon; Emarah, Ziad; Piukovics, Klára; Nucci, Marcio; López-García, Alberto; Rácil, Zdenek; et al. "COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)". Haematologica 108 1 (2022): 22-33. http://dx.doi.org/10.3324/haematol.2022.280847.
    10.3324/haematol.2022.280847
  31. Carolina Lopes; Andreia Costa; Rui Bergantim; Fernando Silveira; Goreti Nadais. "Refractory CIDP successfully treated with autologous haematopoietic stem cell transplantation in a patient with monoclonal gammopathy of undetermined significance (MGUS) and rheumatoid arthritis". Neuromuscular Disorders 32 1 (2022): 71-74. https://doi.org/10.1016/j.nmd.2021.11.008.
    10.1016/j.nmd.2021.11.008
  32. Pagano, Livio; Salmanton-García, Jon; Marchesi, Francesco; Busca, Alessandro; Corradini, Paolo; Hoenigl, Martin; Klimko, Nikolai; et al. "COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)". Journal of Hematology & Oncology 14 1 (2021): http://dx.doi.org/10.1186/s13045-021-01177-0.
    10.1186/s13045-021-01177-0
  33. Tânia Maia; Rui Bergantim; Henrique Costa; Jorge Pinheiro; Fernanda Trigo. "Impact of hematologic complete response in the treatment of sporadic late-onset nemaline myopathy associated with monoclonal gammopathy". Clinical Case Reports 9 7 (2021): https://doi.org/10.1002/ccr3.4471.
    10.1002/ccr3.4471
  34. Sara Peixoto da Silva; Hugo R. Caires; Rui Bergantim; José E. Guimarães; M. Helena Vasconcelos. "miRNAs mediated drug resistance in hematological malignancies". Seminars in Cancer Biology (2021): https://doi.org/10.1016/j.semcancer.2021.03.014.
    10.1016/j.semcancer.2021.03.014
  35. Neves, Manuel; Trigo, Fernanda; Rui, Bergantim; João, Cristina; Lúcio, Paulo; Mariana, Neves; Mendes, João; Pedrosa, Hugo; Geraldes, Catarina. "Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness". PharmacoEconomics 39 5 (2021): 579-587. http://dx.doi.org/10.1007/s40273-020-00993-5.
    10.1007/s40273-020-00993-5
  36. Ribeiro-Carvalho, Francisco; Gonçalves-Pinho, Manuel; Bergantim, Rui; Freitas, Alberto; Fernandes, Lia. "Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations: A Portuguese nationwide study from 2000 to 2015". Psycho-Oncology 29 10 (2020): 1587-1594. http://dx.doi.org/10.1002/pon.5469.
    10.1002/pon.5469
  37. Xavier, Cristina P. R.; Caires, Hugo R.; Barbosa, Mélanie A. G.; Bergantim, Rui; Guimarães, José E.; Vasconcelos, M. Helena. "The Role of Extracellular Vesicles in the Hallmarks of Cancer and Drug Resistance". Cells 9 5 (2020): 1141. http://dx.doi.org/10.3390/cells9051141.
    10.3390/cells9051141
  38. Vanessa Pinto; Rui Bergantim; Hugo R. Caires; Hugo Seca; José E. Guimarães; M. Helena Vasconcelos. "Multiple Myeloma: Available Therapies and Causes of Drug Resistance". Cancers 12 2 (2020): 407-407. https://doi.org/10.3390/cancers12020407.
    10.3390/cancers12020407
  39. Rui Bergantim; Juliana Bastos; Maria José Soares; Bruno Carvalho; Pedro Soares; Cristina Marques; Jennifer Costa; José Eduardo Guimarães; Fernanda Trigo. "Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review". Case Reports in Hematology 2020 (2020): 1-8. https://doi.org/10.1155/2020/8563098.
    10.1155/2020/8563098
  40. João, Cristina; Bergantim, Rui; Neves, Manuel; Chacim, Sérgio; Afonso, Celina; Barradas, João; Bernardo, Manuela; et al. "Multiple myeloma in elderly patients—a Portuguese multicentric real-life study". Annals of Hematology 98 7 (2019): 1689-1701. http://dx.doi.org/10.1007/s00277-019-03640-y.
    10.1007/s00277-019-03640-y
  41. Dimopoulos, M.A.; Gay, F.; Schjesvold, F.; Beksac, M.; Hajek, R.; Weisel, K.C.; Goldschmidt, H.; et al. "Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial". The Lancet 393 10168 (2019): 253-264. http://www.scopus.com/inward/record.url?eid=2-s2.0-85060020572&partnerID=MN8TOARS.
    10.1016/S0140-6736(18)33003-4
  42. Marini, C.; Maia, T.; Bergantim, R.; Pires, J.; Aguiar, E.; Guimarães, J.E.; Trigo, F.. "Real-life data on safety and efficacy of autologous stem cell transplantation in elderly patients with multiple myeloma". Annals of Hematology 98 2 (2019): 369-379. http://www.scopus.com/inward/record.url?eid=2-s2.0-85055958621&partnerID=MN8TOARS.
    10.1007/s00277-018-3528-x
  43. Martins, Elisabete; Urbano, Joana; Leite, Sérgio; Pinto, Adriana; Garcia, Raquel; Bergantim, Rui; Rodrigues-Pereira, Pedro; et al. "Cardiac Amyloidosis Associated with Apolipoprotein A-IV Deposition Diagnosed by Mass Spectrometry-Based Proteomic Analysis". (2019): http://hdl.handle.net/10400.18/6596.
    10.12890/2019_001237
  44. H. Ferreira; M. Bustorff; J. Santos; I. Ferreira; S. Sampaio; I. Salomé; J. Bastos; et al. "Post-transplant Lymphoproliferative Disorder: A Single-Center Experience". Transplantation Proceedings 47 4 (2015): 981-984. http://dx.doi.org/10.1016/j.transproceed.2015.03.017.
    10.1016/j.transproceed.2015.03.017
  45. Hugo Seca; Raquel Lima; Gabriela Almeida; Manuel Sobrinho-Simoes; Rui Bergantim; Jose Guimaraes; M. Vasconcelos. "Effect of miR-128 in DNA Damage of HL-60 Acute Myeloid Leukemia Cells". CPB 15 5 (2014): 492-502. http://dx.doi.org/10.2174/1389201015666140519122524.
    10.2174/1389201015666140519122524
  46. Seca, Hugo; Raquel T. Lima; Almeida, Gabriela M.; Sobrinho-Simões, Manuel; Bergantim, Rui; Guimaraes, Jose E.; Vasconcelos, M. Helena. "ABSTRACT: "Mir-128 and DNA Damage In Acute Myeloid Leukemia"". Blood 122 21 (2013): 2533-2533. http://dx.doi.org/10.1182/blood.v122.21.2533.2533.
    Published • 10.1182/blood.v122.21.2533.2533
  47. Rui Bergantim; Elisabete Rios; Fernanda Trigo; Jose Eduardo Guimarães. "Invasive Coinfection with Aspergillus and Mucor in a Patient with Acute Myeloid Leukemia". Clin Drug Investig 33 S1 (2013): 51-55. http://dx.doi.org/10.1007/s40261-012-0022-4.
    10.1007/s40261-012-0022-4
  48. Cristina Guimarães; Rui Bergantim; Renata Ramalho; Nuno Couto; João T Guimarães; Fernanda Trigo. "Prognostic value of unrelated atypical serum immunofixation patterns during Multiple Myeloma therapy". Journal of Hematology & Oncology 5 1 (2012): 33-33. http://dx.doi.org/10.1186/1756-8722-5-33.
    10.1186/1756-8722-5-33
  49. Rui Bergantim; Fernanda Trigo; José E Guimarães. "Impact of tandem autologous stem cell transplantation and response to transplant in the outcome of multiple myeloma". Experimental Hematology & Oncology 1 1 (2012): 35-35. http://dx.doi.org/10.1186/2162-3619-1-35.
    10.1186/2162-3619-1-35
  50. Pereira,Marco; Bergantim,Rui; Costa,Emília; Morais,Lurdes; Lavrador,Vasco; Barbot,José. "Eritroblastopenia transitória da infância: atitude expectante face a uma anemia grave". (2012): http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-07542012000200011.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2025/03/26 miRNAs como biomarcadores em Mieloma Múltiplo - desafios e oportunidades Conferências em Oncobiologia 2024-25
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
2025/02/22 Imunoterapia em mieloma múltiplo: CAR-T 2ª Reunião Nacional de Mieloma Múltiplo
Grupo Português de Mieloma Múltiplo (Figueira da Foz, Portugal)
2024/02/23 Infections in Multiple Myeloma Multiply Sanofi Oncology Meeting
Sanofi (Porto, Portugal)
2023/12/05 From Bone Marrow to Blood - Liquid Biopsies in Multiple Myeloma" Conferences in Oncobiology 2023/2024
Faculdade de Farmácia da Universidade do Porto (Porto, Portugal)
2023/05/20 Bispecifics for the Treatment of Multiple Myeloma Janssen Hematology Meeting
Janssen (Porto, Portugal)
2023/05/10 Allogeneic and autologous transplantation: what patients and caregivers need to know. Reunião ADL (ADL Meeting)
Associação de Doentes com Leucemia e Linfoma (ADL) (Porto, Portugal)
2023/03/18 EPICOVID & Multiple Myeloma 1ª Reunião Nacional em Mieloma Multiplo
Grupo Português de Mieloma Múltiplo (Figueira da Foz, Portugal)
2023/03/18 Autologous Stem Cell Transplant for MM patients with renal disease 1ª Reunião Nacional em Mieloma Múltiplo
Grupo Português de Mieloma Múltiplo (Figueira da Foz, Portugal)
2022/11/10 BLENREP- Innovation in the treatment of MM, from studies to clinical practice GSK Satellite Symposium - Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia (Tróia, Portugal)
2022/11/09 Ibrutinib, beyond clinical trials - the transformation of treatment at Waldenström macroglobulinemia Janssen Satellite Symposium at the Annual Meeting of the Portuguese Society of Hematology (SPH)
Sociedade Portuguesa de Hematologia (SPH) (Tróia, Portugal)
2022/11/09 Kd as a backbone in the treatment of MMrr Amgen Satellite Symposium - Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia (Tróia, Portugal)
2022/11 How to deal with side effects of treatment and Multiple Myeloma symptoms? Patients and Caregivers Multiple Myeloma Seminar
APCL (Lisbon, Portugal)
2022/10 Multiple Myeloma in Portugal, landscape treatment and clinical options Multiply
Sanofi (Lisbon, Portugal)
2022/10 Workshop: Key considerations to improve the practical management of patients with AL amyloidosis Hematology Summit 2022
HME (Baveno, Italy)
2022/09/16 Interpretação do Leucograma em Cuidados de Saude Primários IV Jornadas NIAG, Desafios Da Hematologia nos CSP
NIAG (Braga, Portugal)
2022/03 AL Amylodoisosis - from diagnosis to treatment, how to manage? Janssen Hematology Meeting
Janssen (Virtual Meeting, Portugal)
2022/01 Car T Cells in Multiple Myeloma Hematology Connect ASH Edition
Gilead, Takeda, Janssen (Virtual Meeting)
2021/11 O impacto das comorbilidades na gestão do doente com Mieloma Multiplo recidivante/refractário Think Multiple Myeloma
Takeda (Virtual Meeting, Portugal)
2021/10 Multiple Myeloma - Complications Management Encontro Jovens Hematologistas
Sociedade Portuguesa de Hematologia (Virtual Meeting, Portugal)
2021/03 High-Dose Melphalan and Autologous Stem Cell Transplantation in AL Amyloidosis XV Congresso Português de Transplantação
Sociedade Portuguesa de Transplantação (Virtual Meeting, Portugal)
2020/02 Treatment of relapsed and refractory Multiple Myeloma Perspectivas em Oncologia VIII
Serviços de Oncologia e Hematologia Clínica, CHUSJ (Porto, Portugal)
2019/11 Waldenström Macroglobulinemia Updates in Hematology
Janssen (Vila Real, Portugal)
2019/11 Venous Thromboembolism in Multiple Myeloma I Course in Venous Thromboembolism
Forum Hematologico do Norte (Porto, Portugal)
2019/10 Multiple Myeloma - current diagnostic and treatment perspectives Lusíadas Grand Rounds
Lusiadas Porto (Porto, Portugal)
2019/10 The PI + IMiD synergism in the treatment of high-risk patients with R/R Multiple Myeloma Think Multiple Myeloma
Takeda (Lisboa, Portugal)
2019/09 Portuguese Multiple Myeloma Group 11th Trialist Forum
European Myeloma Network (Baveno, Italy)
2018/12 Targeted therapies in Hemato-Oncology Conferences in Oncobiology 2018/2019
Faculdade de Farmacia da Universidade do Porto (Porto, Portugal)
2018/10 Autologous hematopoietic cell transplantation for Multiple Myeloma patients with renal insufficiency XIV Congresso Português de Transplantação
Sociedade Portuguesa de Transplantação (Coimbra, Portugal)
2018/03 Clinical Trials in Multiple Myeloma - hope and future International Multiple Myeloma Foundation
Associação Portuguesa Leucemia e Linfomas (Porto, Portugal)
2017/11 CHALLENGES IN MM FOLLOW-UP – what we can get from serum biomarkers? Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia (Algarve, Portugal)
2017/04 Role of HevyLite in Multiple Myeloma XXII Encontro da APAC
Associação Portuguesa de Analistas Clínicos (Coimbra, Portugal)
2017/04 First Line Treatment in Multiple Myeloma Encontros de Primavera Oncologia
Encontros de Primavera Oncologia (Évora, Portugal)
2017/03 Mieloma Múltiplo - estratégias terapêuticas actuais ADL Meeting
Associação Doentes Leucemia e Linfoma (Porto, Portugal)
2016/11 MM Treatment sequencing Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia (Porto, Portugal)
2016/09 Immunotherapy in Hematology HCPA Advanced Course On Oncology/Hematology Therapy
Hospital and Clinical Pharmacy Academy (Lisboa, Portugal)
2016/05 Hematology in primary care Residents Meeting
USF Aqueduto (Vila do Conde, Portugal)
2016/02 Autologous Stem Cell Transplant in Multiple Myeloma Perspectivas em Oncologia IV
Serviços de Oncologia e Hematologia Clínica, CHUSJ (Porto, Portugal)
2015/04 MED Win - Clinical Hematology MED Win
Faculdade de Medicina da Universidade do Porto (Porto, Portugal)
2015/04 Anemia, a clinical perspective 7ª Reunião Científica da SPML
Sociedade Portuguesa de Medicina Laboratorial (Braga)
2015/02 Fungal prophylaxis in hematologic patients II Congresso Internacional de Cuidados Intensivos e Unidades Intermédias do Centro Hospitalar do Porto
Centro Hospitalar do Porto (Porto, Portugal)
2014/11 Myelofibrosis - diagnostic approach Reunião Anual da Sociedade Portuguesa de Hematologia
Sociedade Portuguesa de Hematologia (Évora, Portugal)
2014/05 Impacto da dose cumulativa na sobrevivência global em doentes com Mieloma Múltiplo tratados com bortezomib Reunião Nacional de Enfermeiros de Oncologia
Associação Nacional de Enfermeiros de Oncologia (Luso, Portugal)
2014/04 Peripheral Neuropathy in Multiple Myeloma Review Myeloma
Celgene (Porto, Portugal)
2014/02 Infections in immunosuppressed patients Perspectivas em Oncologia II
Serviços de Oncologia e Hematologia Clínica, CHUSJ (Porto, Portugal)
2014/02 Hematopoietic Stem Cell Transplant - where are we now? Cancer Drug Resistance Group Meeting
Cancer Drug Resistance Group, IPATIMUP (Porto, Portugal)
2013/11 Hypercalcemia in Multiple Myeloma Reunião Anual da Sociedade Portuguesa de Hematologia
Grupo Português de Mieloma Múltiplo (Porto, Portugal)
2013/06 Hemato-Oncology Tutorial for pharmaceutics - acute leukemias, stem cell transplantation, and multiple myeloma 1st Hemato-Oncology Tutorial for Pharmaceutics
Shire (Porto, Portugal)
2010/10 Immune reconstitution after autologous stem cell transplant on multiple myeloma IX Congresso Luso-Brasileiro de Transplantação
(Porto, Portugal)
2010/10 Autologous Stem Cell Transplantation experience of Hospital S. João Clinical Haematology Division in the period 2007-2009 IX Congresso Luso-Brasileiro de Transplantação
(Porto, Portugal)

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2023 - 2024 An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-analysis
Supervisor of Rita Pereira
 Mestrado Integrado (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2020 - 2021 Treatment of Relapsed Acute Promyelocytic Leukemia: a Review of the Literature
Supervisor of Maria Leonor Santos Aguiar
 Mestrado Integrado em Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal
2019 - 2020 Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations – a Portuguese nationwide study from 2000 to 2015
Co-supervisor of Francisco Ribeiro de Carvalho
 Mestrado Integrado em Medicina (Master)
Universidade do Porto Faculdade de Medicina, Portugal

Event organisation

Event name
Type of event (Role) 		Institution / Organization
2024/11/07 - 2024/11/09 Reunião Anual da Sociedade Portuguesa de Hematologia (2024/11/07 - 2024/11/09)
Congress (Member of the Organising Committee)
 Centro Hospitalar Universitário de São João, Portugal
2023/03/18 - 2023/03/18 1ª Reunião Nacional em Mieloma Multiplo (2023/03/18 - 2023/03/18)
Congress (Member of the Organising Committee)
 Grupo Português de Mieloma Múltiplo, Portugal
2023/02/23 - 2023/02/25 Perspectivas em Hematologia I (2023/02/23 - 2023/02/25)
Congress (Member of the Organising Committee)
 Centro Hospitalar Universitário de São João, Portugal
2022/02/17 - 2022/02/19 Perspectivas em Oncologia X (2022/02/17 - 2022/02/19)
Congress (Member of the Organising Committee)
 Centro Hospitalar Universitário de São João, Portugal
2016/11/17 - 2016/11/19 Reunião Anual da Sociedade Portuguesa de Hematologia (2016/11/17 - 2016/11/19)
Congress (Member of the Organising Committee)
 Sociedade Portuguesa de Hematologia, Portugal

Ad Hoc journal article review

Journal title (ISSN) Publisher
2023 - Current Frontiers in Oncology (2234-943X) Frontiers
2021 - Current BMJ case reports (1757-790X) BMJ Journals
2018 - Current Porto Biomedical Journal (2444-8664) Elsiever

Association member

Society Organization name Role
2023 - Current IMMUNO-model COST ACTION CA21135, European Cooperation in Science and Technology Active member; Co-Leader of WG4 - Haematological Diseases; Member of the Managing Committee
2019 - Current European Myeloma Network Active member
2018 - Current International Multiple Myeloma Society Active member
2013 - Current European Society for Blood and Marrow Transplantation Active member
2010 - Current Grupo Português de Mieloma Multiplo Active member; Direction Board since 2017
2008 - Current Sociedade Portuguesa de Hematologia Active member; President of the Fiscal Council since 2023
2008 - Current European Hematology Association Active member
2006 - Current Ordem dos Médicos - Order of Physicians Active member

Conference scientific committee

Conference name Conference host
2025/06/12 - 2025/06/15 European Hematology Association European Hematology Association
2025/02/22 - 2025/02/22 2ª Reunião Anual de Mieloma Múltiplo Grupo Português de Mieloma Múltiplo
2025/02/06 - 2025/02/08 Perspectivas em Hematologia II Serviço de Hematologia Clínica, Centro Hospitalar de Universitário São João
2024/11/07 - 2024/11/09 Reunião Anual da Sociedade Portuguesa de Hematologia, Porto, Portugal Sociedade Portuguesa de Hematologia
2023/11/09 - 2023/11/11 Reunião Anual da Sociedade Portuguesa de Hematologia, Viseu, Portugal Sociedade Portuguesa de Hematologia
2023/02/23 - 2023/02/25 Perspectivas em Hematologia I Serviço de Hematologia Clínica, Centro Hospitalar de Universitário São João
2022/02/17 - 2022/02/19 Perspectivas em Oncologia X Serviços de Oncologia e Hematologia Clínica, Centro Hospitalar de Universitário São João
2021/11/11 - 2021/11/13 Reunião Anual da Sociedade Portuguesa de Hematologia, Espinho, Portugal Sociedade Portuguesa de Hematologia
2021/02/18 - 2021/02/20 Perspectivas em Oncologia IX Serviços de Oncologia e Hematologia Clínica, Centro Hospitalar de Universitário São João
2020/02/13 - 2020/02/15 Perspectivas em Oncologia VIII Serviços de Oncologia e Hematologia Clínica, Centro Hospitalar de Universitário São João

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2023 - Current Platelet disorders Intensive course in Hematology (Outros) Dioscope, Portugal
2021 - Current Immunotherapy in Multiple Myeloma Unidade de Formação Contínua em Imunoterapia e Imunomodulação (Pós-Graduação) Universidade do Porto Faculdade de Medicina, Portugal
2019 - Current Multiple Myeloma Unidade de Formação Continua em Mieloma Múltiplo (Pós-Graduação) Universidade do Porto Faculdade de Medicina, Portugal
2023/11/09 - 2023/11/09 AL Amyloidosis and other Monoclonal Gammapathies of Clinical Significance One day course (Outros) Grupo Português de Mieloma Múltiplo, Portugal
2022/11/10 - 2022/11/10 Future prospects for cytometry and nuclear medicine in Multiple Myeloma One day course (Outros) Grupo Português de Mieloma Múltiplo, Portugal
2022 - 2022 Malignant diseases associated with HTLV-1 Unidade Curricular de Virologia Clínica (Mestrado) Universidade do Porto Faculdade de Farmácia, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2024/07/16 - 2024/07/16 Effective member of the jury in the institutional procedure for the category of medical assistant (Clinical Hematology)
Evaluator
 Unidade Local de Saúde do Tâmega e Sousa, Portugal Governo da República Portuguesa Ministério da Saúde
2024/03/19 - 2024/03/21 Effective member of the Final Evaluation Jury of the Hematology Residency Program
Evaluator
 Centro Hospitalar de Vila Nova de Gaia Espinho EPE, Portugal Ordem dos Médicos
2023/10/23 - 2023/10/24 Effective member of the Final Evaluation Jury of the Hematology Residency Program
Evaluator
 Centro Hospitalar Universitário de São João, Portugal Ordem dos Médicos
2021/04/26 - 2021/04/28 Effective member of the Final Evaluation Jury of the Hematology Residency Program
Evaluator
 Centro Hospitalar de Trás-os-montes e Alto Douro EPE, Portugal Ordem dos Médicos
2018/10/18 - 2018/10/19 Effective member of the Final Evaluation Jury of the Hematology Residency Program
Evaluator
 Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal Ordem dos Médicos
2015/10/29 - 2015/10/30 Effective member of the Final Evaluation Jury of the Hematology Residency Program
Evaluator
 Hospital Santo António dos Capuchos, Portugal Ordem dos Médicos

Interview (newspaper / magazine)

Activity description Newspaper / Forum
2023/10/24 What are the latest updates to the Portuguese MM treatment guidelines? Multiple Myeloma Hub
2021/12/17 A medicina personalizada em hemato-oncologia Abordagem única e dirigida substitui a clássica “one-drug-fits-all” Sinal Aberto

Interview (tv / radio show)

Program Topic
2017/11/09 - 2017/11/09 Aprofundar o Mieloma Múltiplo Quais as vantagens do tratamento continuado no mieloma múltiplo?

Mentoring / Tutoring

Topic Student name
2019 - 2024 Coordinator of the Clinical Hematology Residency at Centro Hospitalar Universitário São João, Porto, Portugal Residents in Clinical Hematology
2019 - 2021 Internato de Formação Especifica - Hematologia Clínica Tânia Maia
2013 - 2018 Internato de Formação Especifica - Hematologia Clínica Juliana Bastos
Distinctions

Award

2025 Best oral presentation: "Sindrome de POEMS, experiência de um centro de transplantação"
Perspectivas em Hematologia, Portugal
2021 2nd Best Poster: "Efeito cumulativo dos hits citogenéticos na recaída após transplante autólogo em Mieloma Múltiplo"
Sociedade Portuguesa de Hematologia, Portugal
2020 Best poster: "Tratamento de resgate com segundo transplante autólogo de progenitores hematopoiéticos no mieloma múltiplo em recaída/progressão"
Perspectivas em Oncologia, Portugal
2020 4th Best oral presentation: "Tratamento de resgate com segundo transplante autólogo de progenitores hematopoiéticos no mieloma múltiplo em recaída/progressão"
Janssen-Cilag Farmacêutica Lda, Portugal
2019 3rd Best Oral Presentation Clinical Series : "Single center experience on Ixazomib in Combination with Lenalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma"
Janssen-Cilag Farmacêutica Lda, Portugal
2018 2rd Best Oral Presentation Case Reports: "Miopatia nemalínica esporádico do adulto associada a MGUS, um equivalente de Mieloma Múltiplo?"
Janssen-Cilag Farmacêutica Lda, Portugal
2018 2nd Best Oral Presentation Clinical Series: "Safety and Efficacy of Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma"
Janssen-Cilag Farmacêutica Lda, Portugal
2018 3rd Best Oral Presentation Clinical Series: "Mortalidade precoce na leucemia promielocítica aguda – análise retrospectiva de dados da vida real"
Janssen-Cilag Farmacêutica Lda, Portugal
2016 1st Best Oral Presentation Case Reports "Central nervous system relapse in multiple myeloma after autologous stem cell transplant"
Janssen-Cilag Farmacêutica Lda, Portugal
2011 Bolsa D. Maria do Livramento de Abreu Forjaz para Investigação Clinica
Nucleo Açoriano da Liga Portuguesa Contra o Cancro, Portugal
2011 Bolsa para treino avançado em Hemato-Oncologia
Associação Portuguesa Contra a Leucemia, Portugal

Fundação Calouste Gulbenkian, Portugal

Title

2024 Prémio Nacional de Hematologia
Sociedade Portuguesa de Hematologia, Portugal
2009 Jovem Hematologista
Sociedade Portuguesa de Hematologia, Portugal